Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Robert Sidwell
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Physiology
Disorders
Anatomy
Sign-in to see full Profile
Network (preview)
46
Smee, Donald
36
Huffman, JH
33
Morrey, John
33
Bailey, Kevin
28
Barnard, Dale
25
Wong, Min-Hui
21
Warren, RP
11
Julander, Justin
9
Jung, Kie-Hoon
9
Day, Craig
9
Gowen, Brian
7
Blatt, Lawrence
7
Wandersee, Miles
6
Mead, Jan
4
Olsen, Aaron
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Robert Sidwell (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2008: Barnard Dale L; Day Craig W; Bailey Kevin; Heiner Matthew; Montgomery Robert; Lauridsen Larry; Jung Kie-Hoon; Li Joseph K-K; Chan Paul K S; Sidwell Robert W
Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse model.
Antiviral research 2008;79(2):105-13.
-
2008: Smee Donald F; Gowen Brian B; Wandersee Miles K; Wong Min-Hui; Skirpstunas Ramona T; Baldwin Thomas J; Hoopes Justin D; Sidwell Robert W
Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment.
International journal of antimicrobial agents 2008;31(4):352-9.
-
2008: Gowen Brian B; Wong Min-Hui; Jung Kie-Hoon; Blatt Lawrence M; Sidwell Robert W
Prophylactic and therapeutic intervention of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with interferon alfacon-1.
Antiviral research 2008;77(3):215-24.
-
2008: Subramanian G Mani; Moore Paul A; Gowen Brian B; Olsen Aaron L; Barnard Dale L; Paragas Jason; Hogan Robert J; Sidwell Robert W
Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus.
Chemotherapy 2008;54(3):176-80.
-
2008: Fatemi S Hossein; Reutiman Teri J; Folsom Timothy D; Sidwell Robert W
The role of cerebellar genes in pathology of autism and schizophrenia.
Cerebellum (London, England) 2008;7(3):279-94.
-
2007: Smee Donald F; Hurst Brett L; Wong Min-Hui; Glazer Robert I; Rahman Aquilur; Sidwell Robert W
Efficacy of N-methanocarbathymidine in treating mice infected intranasally with the IHD and WR strains of vaccinia virus.
Antiviral research 2007;76(2):124-9.
-
2007: Gowen Brian B; Wong Min-Hui; Jung Kie-Hoon; Sanders Andrew B; Mendenhall Michelle; Bailey Kevin W; Furuta Yousuke; Sidwell Robert W
In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections.
Antimicrobial agents and chemotherapy 2007;51(9):3168-76.
-
2007: Olsen Aaron L; Morrey John D; Smee Donald F; Sidwell Robert W
Correlation between breakdown of the blood-brain barrier and disease outcome of viral encephalitis in mice.
Antiviral research 2007;75(2):104-12.
-
2007: Julander Justin G; Judge John W; Olsen Aaron L; Rosenberg Barnett; Schafer Kristiina; Sidwell Robert W
Prophylactic treatment with recombinant Eimeria protein, alone or in combination with an agonist cocktail, protects mice from Banzi virus infection.
Antiviral research 2007;75(1):14-9.
-
2007: Julander Justin G; Furuta Yousuke; Shafer Kristiina; Sidwell Robert W
Activity of T-1106 in a hamster model of yellow Fever virus infection.
Antimicrobial agents and chemotherapy 2007;51(6):1962-6.
-
2007: Gowen Brian B; Wong Min-Hui; Jung Kie-Hoon; Sanders Andrew B; Mitchell William M; Alexopoulou Lena; Flavell Richard A; Sidwell Robert W
TLR3 is essential for the induction of protective immunity against Punta Toro Virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not Poly(I:C): differential recognition of synthetic dsRNA molecules.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(8):5200-8.
-
2007: Julander Justin G; Siddharthan Venkatraman; Blatt Lawrence M; Schafer Kristiina; Sidwell Robert W; Morrey John D
Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model.
Virology 2007;360(2):454-60.
-
2007: Sidwell Robert W; Barnard Dale L; Day Craig W; Smee Donald F; Bailey Kevin W; Wong Min-Hui; Morrey John D; Furuta Yousuke
Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice.
Antimicrobial agents and chemotherapy 2007;51(3):845-51.
-
2007: Julander Justin G; Morrey John D; Blatt Lawrence M; Shafer Kristiina; Sidwell Robert W
Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model.
Antiviral research 2007;73(2):140-6.
-
2007: Smee Donald F; Wandersee Miles K; Bailey Kevin W; Wong Min-Hui; Chu Chung K; Gadthula Srinivas; Sidwell Robert W
Cell line dependency for antiviral activity and in vivo efficacy of N-methanocarbathymidine against orthopoxvirus infections in mice.
Antiviral research 2007;73(1):69-77.
-
2007: Barnard Dale L; Wong Min-Hui; Bailey Kevin; Day Craig W; Sidwell Robert W; Hickok Stephen S; Hall Tony J
Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice.
Antiviral chemistry & chemotherapy 2007;18(3):125-32.
-
2006: Gowen Brian B; Hoopes Justin D; Wong Min-Hui; Jung Kie-Hoon; Isakson Kevin C; Alexopoulou Lena; Flavell Richard A; Sidwell Robert W
TLR3 deletion limits mortality and disease severity due to Phlebovirus infection.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(9):6301-7.
-
2006: Sidwell Robert W; Barnard Dale L
Respiratory syncytial virus infections: recent prospects for control.
Antiviral research 2006;71(2-3):379-90.
-
2006: Barnard Dale L; Day Craig W; Bailey Kevin; Heiner Matthew; Montgomery Robert; Lauridsen Larry; Winslow Scott; Hoopes Justin; Li Joseph K-K; Lee Jongdae; Carson Dennis A; Cottam Howard B; Sidwell Robert W
Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
Antiviral research 2006;71(1):53-63.
-
2006: Gowen Brian B; Smee Donald F; Wong Min-Hui; Judge John W; Jung Kie-Hoon; Bailey Kevin W; Pace Anne M; Rosenberg Barnett; Sidwell Robert W
Recombinant Eimeria protozoan protein elicits resistance to acute phlebovirus infection in mice but not hamsters.
Antimicrobial agents and chemotherapy 2006;50(6):2023-9.
-
2006: Malakhov Michael P; Aschenbrenner Laura M; Smee Donald F; Wandersee Miles K; Sidwell Robert W; Gubareva Larisa V; Mishin Vasiliy P; Hayden Frederick G; Kim Do Hyong; Ing Alice; Campbell Erin R; Yu Mang; Fang Fang
Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection.
Antimicrobial agents and chemotherapy 2006;50(4):1470-9.
-
2006: Gowen Brian B; Fairman Jeff; Smee Donald F; Wong Min-Hui; Jung Kie-Hoon; Pace Anne M; Heiner Matthew L; Bailey Kevin W; Dow Steven W; Sidwell Robert W
Protective immunity against acute phleboviral infection elicited through immunostimulatory cationic liposome-DNA complexes.
Antiviral research 2006;69(3):165-72.
-
2006: Julander Justin G; Winger Quinton A; Rickords Lee F; Shi Pei-Yong; Tilgner Mark; Binduga-Gajewska Iwona; Sidwell Robert W; Morrey John D
West Nile virus infection of the placenta.
Virology 2006;347(1):175-82.
-
2006: Chu Chung K; Gadthula Srinivas; Chen Xin; Choo Hyunah; Olgen Sureyya; Barnard Dale L; Sidwell Robert W
Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-coV).
Antiviral chemistry & chemotherapy 2006;17(5):285-9.
-
2006: Barnard Dale L; Day Craig W; Bailey Kevin; Heiner Matthew; Montgomery Robert; Lauridsen Larry; Chan Paul K S; Sidwell Robert W
Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice.
Antiviral chemistry & chemotherapy 2006;17(5):275-84.
-
2006: Selvam Periyasamy; Murugesh Narayanan; Chandramohan Markandavel; Sidwell Robert W; Wandersee Miles K; Smee Donald F
Anti-influenza virus activities of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6-dimethyl-2-pyrimidin-2-yl)benzenesulphonamide and its derivatives.
Antiviral chemistry & chemotherapy 2006;17(5):269-74.
-
2006: Smee Donald F; Wong Min-Hui; Bailey Kevin W; Sidwell Robert W
Activities of oseltamivir and ribavirin used alone and in combination against infections in mice with recent isolates of influenza A (H1N1) and B viruses.
Antiviral chemistry & chemotherapy 2006;17(4):185-92.
-
2006: Gowen Brian B; Smee Donald F; Wong Min-Hui; Pace Anne M; Jung Kie-Hoon; Bailey Kevin W; Blatt Lawrence M; Sidwell Robert W
Combinatorial ribavirin and interferon alfacon-1 therapy of acute arenaviral disease in hamsters.
Antiviral chemistry & chemotherapy 2006;17(4):175-83.
-
2005: Sidwell Robert W; Bailey K W; Wong M-H; Barnard D L; Smee D F
In vitro and in vivo influenza virus-inhibitory effects of viramidine.
Antiviral research 2005;68(1):10-7.
-
2005: Day Craig W; Smee Donald F; Julander Justin G; Yamshchikov Vladimir F; Sidwell Robert W; Morrey John D
Error-prone replication of West Nile virus caused by ribavirin.
Antiviral research 2005;67(1):38-45.
-
2005: Gowen Brian B; Barnard Dale L; Smee Donald F; Wong Min-Hui; Pace Anne M; Jung Kie-Hoon; Winslow Scott G; Bailey Kevin W; Blatt Lawrence M; Sidwell Robert W
Interferon alfacon-1 protects hamsters from lethal pichinde virus infection.
Antimicrobial agents and chemotherapy 2005;49(6):2378-86.
-
2005: Julander Justin G; Winger Quinton A; Olsen Aaron L; Day Craig W; Sidwell Robert W; Morrey John D
Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival.
Antiviral research 2005;65(2):79-85.
-
2005: Smee Donald F; Wandersee Miles K; Bailey Kevin W; Hostetler Karl Y; Holy Antonin; Sidwell Robert W
Characterization and treatment of cidofovir-resistant vaccinia (WR strain) virus infections in cell culture and in mice.
Antiviral chemistry & chemotherapy 2005;16(3):203-11.
-
2004: Wang Peiyuan; Hollecker Laurent; Pankiewicz Krzysztof W; Patterson Steven E; Whitaker Tony; McBrayer Tamara R; Tharnish Phillip M; Sidwell Robert W; Stuyver Lieven J; Otto Michael J; Schinazi Raymond F; Watanabe Kyoichi A
Synthesis of N3,5'-cyclo-4-(beta-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one, a novel compound with anti-hepatitis C virus activity.
Journal of medicinal chemistry 2004;47(24):6100-3.
-
2004: Smee Donald F; Wandersee Miles K; Wong Min-Hui; Bailey Kevin W; Sidwell Robert W
Treatment of mannan-enhanced influenza B virus infections in mice with oseltamivir, ribavirin and viramidine.
Antiviral chemistry & chemotherapy 2004;15(5):261-8.
-
2004: Smee Donald F; Bailey Kevin W; Wong Min-Hui; Wandersee Miles K; Sidwell Robert W
Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice.
The Journal of infectious diseases 2004;190(6):1132-9.
-
2004: Morrey John D; Day Craig W; Julander Justin G; Olsen Aaron L; Sidwell Robert W; Cheney Carl D; Blatt Lawrence M
Modeling hamsters for evaluating West Nile virus therapies.
Antiviral research 2004;63(1):41-50.
-
2004: Smee Donald F; Wong Min-Hui; Bailey Kevin W; Beadle James R; Hostetler Karl Y; Sidwell Robert W
Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice.
International journal of antimicrobial agents 2004;23(5):430-7.
-
2004: Barnard D L; Hubbard V D; Smee D F; Sidwell R W; Watson K G W; Tucker S P T; Reece P A R
In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity.
Antimicrobial agents and chemotherapy 2004;48(5):1766-72.
-
2004: Morrey John D; Day Craig W; Julander Justin G; Blatt Lawrence M; Smee Donald F; Sidwell Robert W
Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models.
Antiviral chemistry & chemotherapy 2004;15(2):101-9.
-
2004: Barnard Dale L; Hubbard Valerie D; Burton Jared; Smee Donald F; Morrey John D; Otto Michael J; Sidwell Robert W
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine.
Antiviral chemistry & chemotherapy 2004;15(1):15-22.
-
2004: Smee Donald F; Sidwell Robert W
Anti-cowpox virus activities of certain adenosine analogs, arabinofuranosyl nucleosides, and 2'-fluoro-arabinofuranosyl nucleosides.
Nucleosides, nucleotides & nucleic acids 2004;23(1-2):375-83.
-
2003: Sidwell R W; Bailey K W; Morrey J D; Wong M H; Baldwin T J; Smee D F
Inhibition of influenza virus infections in immunosuppressed mice with orally administered peramivir (BCX-1812).
Antiviral research 2003;60(1):17-25.
-
2003: Julander Justin G; Colonno Richard J; Sidwell Robert W; Morrey John D
Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus.
Antiviral research 2003;59(3):155-61.
-
2003: Watson Keith G; Brown Renee N; Cameron Rachel; Chalmers David K; Hamilton Stephanie; Jin Betty; Krippner Guy Y; Luttick Angela; McConnell Darryl B; Reece Phillip A; Ryan Jane; Stanislawski Pauline C; Tucker Simon P; Wu Wen-Yang; Barnard Dale L; Sidwell Robert W
An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus.
Journal of medicinal chemistry 2003;46(15):3181-4.
-
2003: Smee Donald F; Bailey Kevin W; Sidwell Robert W
Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice.
Chemotherapy 2003;49(3):126-31.
-
2003: Sidwell Robert W; Smee Donald F
Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control.
Antiviral research 2003;57(1-2):101-11.
-
2003: Smee Donald F; Sidwell Robert W
A review of compounds exhibiting anti-orthopoxvirus activity in animal models.
Antiviral research 2003;57(1-2):41-52.
-
2002: Smee Donald F; Morrison Ann C; Barnard Dale L; Sidwell Robert W
Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds.
Journal of virological methods 2002;106(1):71-9.
-
2002: Morrey John D; Smee Donald F; Sidwell Robert W; Tseng Christopher
Identification of active antiviral compounds against a New York isolate of West Nile virus.
Antiviral research 2002;55(1):107-16.
-
2002: Julander Justin G; Sidwell Robert W; Morrey John D
Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus.
Antiviral research 2002;55(1):27-40.
-
2002: Sidwell Robert W; Smee Donald F
Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza.
Expert opinion on investigational drugs 2002;11(6):859-69.
-
2002: Smee Donald F; Bailey Kevin W; Sidwell Robert W
Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug.
Antiviral research 2002;54(2):113-20.
-
2002: Smee Donald F; Bailey Kevin W; Morrison Ann C; Sidwell Robert W
Combination treatment of influenza A virus infections in cell culture and in mice with the cyclopentane neuraminidase inhibitor RWJ-270201 and ribavirin.
Chemotherapy 2002;48(2):88-93.
-
2002: Smee Donald F; Sidwell Robert W; Kefauver Debbie; Bray Mike; Huggins John W
Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.
Antimicrobial agents and chemotherapy 2002;46(5):1329-35.
-
2002: Barnard Dale L; Xu Z e Q i; Stowell Valerie D; Yuan Hongwei; Smee Donald F; Samy Raghu; Sidwell Robert W; Nielsen M Kim; Sun Lihui; Cao Hua; Li Ailing; Quint Clay; Deignan Jeffrey; Crabb Jennifer; Flavin Michael T
Coumarins and pyranocoumarins, potential novel pharmacophores for inhibition of measles virus replication.
Antiviral chemistry & chemotherapy 2002;13(1):39-59.
-
2001: Smee D F; Sidwell R W; Morrison A C; Bailey K W; Baum E Z; Ly L; Wagaman P C
Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.
Antiviral research 2001;52(3):251-9.
-
2001: Sidwell R W; Wong M H; Bailey K W; Barnard D L; Jackson M K; Smee D F
Utilization of alpha-1-acid glycoprotein levels in the serum as a parameter for in vivo assay of influenza virus inhibitors.
Antiviral chemistry & chemotherapy 2001;12(6):359-65.
-
2001: Smee D F; Bailey K W; Wong M H; Sidwell R W
Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice.
Antiviral research 2001;52(1):55-62.
-
2001: Sidwell R W; Smee D F; Huffman J H; Barnard D L; Morrey J D; Bailey K W; Feng W C; Babu Y S; Bush K
Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201.
Antiviral research 2001;51(3):179-87.
-
2001: Barnard D L; Stowell V D; Seley K L; Hegde V R; Das S R; Rajappan V P; Schneller S W; Smee D F; Sidwell R W
Inhibition of measles virus replication by 5'-nor carbocyclic adenosine analogues.
Antiviral chemistry & chemotherapy 2001;12(4):241-50.
-
2001: Sidwell R W; Smee D F; Bailey K W; Burger R A
Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice.
International immunopharmacology 2001;1(6):1211-8.
-
2001: Sidwell R W; Smee D F; Huffman J H; Barnard D L; Bailey K W; Morrey J D; Babu Y S
In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201.
Antimicrobial agents and chemotherapy 2001;45(3):749-57.
-
2001: Smee D F; Huffman J H; Morrison A C; Barnard D L; Sidwell R W
Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities.
Antimicrobial agents and chemotherapy 2001;45(3):743-8.
-
2001: Smee D F; Bailey K W; Sidwell R W
Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir.
Antiviral chemistry & chemotherapy 2001;12(1):71-6.
-
2000: Sidwell R W; Smee D F
In vitro and in vivo assay systems for study of influenza virus inhibitors.
Antiviral research 2000;48(1):1-16.
-
2000: Yasuda S; Huffman J H; Smee D F; Sidwell R W; Miyata K
Spectrum of virus inhibition by consensus interferon YM643.
Antiviral chemistry & chemotherapy 2000;11(5):337-41.
-
2000: Smee D F; Bailey K W; Wong M; Sidwell R W
Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir.
Antiviral research 2000;47(3):171-7.
-
2000: Smee D F; Bailey K W; Sidwell R W
Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir.
Antiviral chemistry & chemotherapy 2000;11(4):303-9.
-
2000: Burger R A; Billingsley J L; Huffman J H; Bailey K W; Kim C U; Sidwell R W
Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice.
Immunopharmacology 2000;47(1):45-52.
-
1999: Sidwell R W; Bailey K W; Bemis P A; Wong M H; Eisenberg E J; Huffman J H
Influence of treatment schedule and viral challenge dose on the in vivo influenza virus-inhibitory effects of the orally administered neuraminidase inhibitor GS 4104.
Antiviral chemistry & chemotherapy 1999;10(4):187-93.
-
1999: Morrey J D; Bailey K W; Korba B E; Sidwell R W
Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine.
Antiviral research 1999;42(2):97-108.
-
1999: Barnard D L; Sidwell R W; Xiao W; Player M R; Adah S A; Torrence P F
2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection.
Antiviral research 1999;41(3):119-34.
-
1999: Jackson M K; Mitchell E A; Winslow S G; Okelberry K M; Sidwell R W; Morrey J D
Resistance to Friend leukemia virus in transgenic mice expressing the native Fv-4 gene.
Acta virologica 1999;43(1):19-23.
-
1998: Tai C Y; Escarpe P A; Sidwell R W; Williams M A; Lew W; Wu H; Kim C U; Mendel D B
Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.
Antimicrobial agents and chemotherapy 1998;42(12):3234-41.
-
1998: Mendel D B; Tai C Y; Escarpe P A; Li W; Sidwell R W; Huffman J H; Sweet C; Jakeman K J; Merson J; Lacy S A; Lew W; Williams M A; Zhang L; Chen M S; Bischofberger N; Kim C U
Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection.
Antimicrobial agents and chemotherapy 1998;42(3):640-6.
-
1998: Sidwell R W; Huffman J H; Barnard D L; Bailey K W; Wong M H; Morrison A; Syndergaard T; Kim C U
Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
Antiviral research 1998;37(2):107-20.
-
1998: Morrey J D; Korba B E; Sidwell R W
Transgenic mice as a chemotherapeutic model for hepatitis B virus infection.
Antiviral therapy 1998;3(Suppl 3):59-68.
-
1997: Barnard D L; Hill C L; Gage T; Matheson J E; Huffman J H; Sidwell R W; Otto M I; Schinazi R F
Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes.
Antiviral research 1997;34(1):27-37.
-
1997: Judd A K; Sanchez A; Bucher D J; Huffman J H; Bailey K; Sidwell R W
In vivo anti-influenza virus activity of a zinc finger peptide.
Antimicrobial agents and chemotherapy 1997;41(3):687-92.
-
1996: Smee D F; Sidwell R W; Barnett B B
Combination of antiviral immunotoxin and ganciclovir or cidofovir for the treatment of murine cytomegalovirus infections.
Antiviral research 1996;32(3):165-71.
-
1996: Sidwell R W; Huffman J H; Bailey K W; Wong M H; Nimrod A; Panet A
Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infections in mice.
Antimicrobial agents and chemotherapy 1996;40(11):2626-31.
-
1996: Smee D F; Sidwell R W; Huffman J H; Huggins J W; Kende M; Verbiscar A J
Antiviral activities of tragacanthin polysaccharides on Punta Toro virus infections in mice.
Chemotherapy 1996;42(4):286-93.
-
1996: Barnett B B; Smee D F; Malek S M; Sidwell R W
Selective cytotoxicity of ricin A chain immunotoxins towards murine cytomegalovirus-infected cells.
Antimicrobial agents and chemotherapy 1996;40(2):470-2.
-
1995: Barnard D L; Fairbairn D W; O'Neill K L; Gage T L; Sidwell R W
Anti-human cytomegalovirus activity and toxicity of sulfonated anthraquinones and anthraquinone derivatives.
Antiviral research 1995;28(4):317-29.
-
1995: Sidwell R W; Bailey K W; Wong M H; Huffman J H
In vitro and in vivo sensitivity of a non-mouse-adapted influenza A (Beijing) virus infection to amantadine and ribavirin.
Chemotherapy 1995;41(6):455-61.
-
1995: Barnett B B; Smee D F; Malek S M; Sidwell R W
Selective cytotoxicity towards cytomegalovirus-infected cells by immunotoxins consisting of gelonin linked to anti-cytomegalovirus antibody.
Antiviral research 1995;28(1):93-100.
-
1995: Burger R A; Warren R P; Huffman J H; Sidwell R W
Effect of methionine enkephalin on natural killer cell and cytotoxic T lymphocyte activity in mice infected with influenza A virus.
Immunopharmacology and immunotoxicology 1995;17(2):323-34.
-
1995: Chirigos M A; Talor E; Sidwell R W; Burger R A; Warren R P
Leukocyte Interleukin, Inj. (LI) augmentation of natural killer cells and cytolytic T-lymphocytes.
Immunopharmacology and immunotoxicology 1995;17(2):247-64.
-
1995: Sidwell R W; Warren R P; Okleberry K; Burger R A; Morrey J D
Effect of the combination of interferon-alpha and stavudine on Friend virus infections in (B10.A x A.By)F1 mice.
The Journal of infectious diseases 1995;171 Suppl 2():S93-8.
-
1995: Smee D F; Sugiyama S T; Sidwell R W; Barnett B B
Effects of monoclonal antibody combined with ganciclovir or (S)-1-[3-hydroxy-(2-phosphonylmethoxy)-propyl]cytosine against murine cytomegalovirus infections in cell culture and in severe combined immunodeficient mice.
Chemotherapy 1995;41(2):141-8.
-
1995: Sidwell R W; Smee D F; Huffman J H; Bailey K W; Warren R P; Burger R A; Penney C L
Antiviral activity of an immunomodulatory lipophilic desmuramyl dipeptide analog.
Antiviral research 1995;26(2):145-59.
-
1995: Smee D F; Barnett B B; Sidwell R W; Reist E J; Holy A
Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
Antiviral research 1995;26(1):1-9.
-
1994: Sidwell R W; Huffman J H; Barnard D L; Smee D F; Warren R P; Chirigos M A; Kende M; Huggins J
Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections.
Antiviral research 1994;25(2):105-22.
-
1994: Lillie J W; Smee D F; Huffman J H; Hansen L J; Sidwell R W; Kaddurah-Daouk R
Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits the replication of human herpes viruses.
Antiviral research 1994;23(3-4):203-18.
-
1994: Sidwell R W; Huffman J H; Moscon B J; Warren R P
Influenza virus-inhibitory effects of intraperitoneally and aerosol-administered SP-303, a plant flavonoid.
Chemotherapy 1994;40(1):42-50.
-
1994: Morrey J D; Bourn S M; Morris J L; Bunch T D; Sidwell R W
Activation of the human immunodeficiency virus long terminal repeat by abrasion of the skin in transgenic mice.
Intervirology 1994;37(6):315-20.
-
1993: Barnard D L; Huffman J H; Sidwell R W; Reist E J
Selective inhibition of cytomegaloviruses by 9-(3'-ethylphosphono-1'-hydroxymethyl-1'-propyloxy-methyl)g uanine.
Antiviral research 1993;22(1):77-89.
-
1993: Sidwell R W; Morrey J D; Okleberry K M; Burger R A; Warren R P
Immunomodulator effects on the Friend virus infection in genetically defined mice.
Annals of the New York Academy of Sciences 1993;685():432-46.
-
1993: Barnard D L; Huffman J H; Meyerson L R; Sidwell R W
Mode of inhibition of respiratory syncytial virus by a plant flavonoid, SP-303.
Chemotherapy 1993;39(3):212-7.
-
1993: Barnard D L; Smee D F; Huffman J H; Meyerson L R; Sidwell R W
Antiherpesvirus activity and mode of action of SP-303, a novel plant flavonoid.
Chemotherapy 1993;39(3):203-11.
-
1993: Sidwell R W; Smee D F; Warren R P; Huffman J H; Gilbert B J; Burger R A; Pearson F C
Murine cytomegalovirus-inhibitory effects of ImuVert.
Antiviral research 1993;20(4):279-92.
-
1993: Smee D F; Gilbert J; Leonhardt J A; Barnett B B; Huggins J H; Sidwell R W
Treatment of lethal Pichinde virus infections in weanling LVG/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen.
Antiviral research 1993;20(1):57-70.
-
1993: Mead J R; Burger R A; Morrey J D; Warren R P; Okleberry K M; Sidwell R W
Effect of immunomodulators in the hu-PBL-SCID mouse model.
Biotechnology therapeutics 1993;4(1-2):133-43.
-
1993: Morrey J D; Jackson M K; Bunch T D; Sidwell R W
Activation of the human immunodeficiency virus type 1 long terminal repeat by skin-sensitizing chemicals in transgenic mice.
Intervirology 1993;36(2):65-71.
-
1992: Morrey J D; Bourn S M; Bunch T D; Sidwell R W; Rosen C A
HIV-1 LTR activation model: evaluation of various agents in skin of transgenic mice.
Journal of acquired immune deficiency syndromes 1992;5(12):1195-203.
-
1992: Sidwell R W; Hitchcock M; Okleberry K M; Burger R A; Warren R P; Morrey J D
Suppression of murine retroviral disease by 2',3'-didehydro-2',3'-dideoxythymidine (D4T).
Antiviral research 1992;19(4):313-24.
-
1992: Warren R P; Morrey J D; Burger R A; Okleberry K M; Sidwell R W
Murine retroviral disease-enhancing effects of a pyrimidinone immunomodulator.
Antiviral research 1992;19(3):233-45.
-
1992: Smee D F; Morris J L; Leonhardt J A; Mead J R; Holy A; Sidwell R W
Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine.
Antimicrobial agents and chemotherapy 1992;36(9):1837-42.
-
1992: Warren R P; Burger R A; Sidwell R W; Clark L L
Effect of triacontanol on numbers and functions of cells involved in inflammatory responses.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1992;200(3):349-52.
-
1992: Sidwell R W; Huffman J H; Smee D F; Gilbert J; Gessaman A; Pease A; Warren R P; Huggins J; Kende M
Potential role of immunomodulators for treatment of phlebovirus infections of animals.
Annals of the New York Academy of Sciences 1992;653():344-55.
-
1992: Morrey J D; Mead J R; Warren R P; Okleberry K M; Burger R A; Sidwell R W
Elucidation of mode of retroviral-inhibitory effects of imexon through use of immune competent and severe combined immune deficiency (SCID) mice.
Antiviral research 1992;17(3):223-33.
-
1992: Sidwell R W; Huffman J H; Gilbert J; Moscon B; Pedersen G; Burger R; Warren R P
Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice.
Antimicrobial agents and chemotherapy 1992;36(2):473-6.
-
1992: Barnard D L; Huffman J H; Morris J L; Wood S G; Hughes B G; Sidwell R W
Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus.
Antiviral research 1992;17(1):63-77.
-
1991: Mead J R; Arrowood M J; Healey M C; Sidwell R W
Cryptosporidial infections in SCID mice reconstituted with human or murine lymphocytes.
The Journal of protozoology 1991;38(6):59S-61S.
-
1991: Smee D F; Burger R A; Coombs J; Huffman J H; Sidwell R W
Progressive murine cytomegalovirus disease after termination of ganciclovir therapy in mice immunosuppressed by cyclophosphamide treatment.
The Journal of infectious diseases 1991;164(5):958-61.
-
1991: Morrey J D; Bourn S M; Bunch T D; Jackson M K; Sidwell R W; Barrows L R; Daynes R A; Rosen C A
In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice.
Journal of virology 1991;65(9):5045-51.
-
1991: Mead J R; Arrowood M J; Sidwell R W; Healey M C
Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice.
The Journal of infectious diseases 1991;163(6):1297-304.
-
1991: Mead J R; Burger R A; Yonk L J; Coombs J; Warren R P; Kende M; Huggins J; Sidwell R W
Effect of human, recombinant interleukin 2 on Punta Toro virus infections in C57BL/6 mice.
Antiviral research 1991;15(4):331-40.
-
1991: Smee D F; Huffman J H; Gessaman A C; Huggins J W; Sidwell R W
Prophylactic and therapeutic activities of 7-thia-8-oxoguanosine against Punta Toro virus infections in mice.
Antiviral research 1991;15(3):229-39.
-
1991: Barnett B B; Burns N J; Park K J; Dawson M I; Kende M; Sidwell R W
Antiviral immunotoxins: antibody-mediated delivery of gelonin inhibits Pichinde virus replication in vitro.
Antiviral research 1991;15(2):125-38.
-
1991: Morrey J D; Warren R P; Okleberry K M; Burger R A; Chirigos M A; Sidwell R W
Effect of imexon treatment on Friend virus complex infection using genetically defined mice as a model for HIV-1 infection.
Antiviral research 1991;15(1):51-65.
-
1991: Morrey J D; Okleberry K M; Sidwell R W
Early-initiated zidovudine therapy prevents disease but not low levels of persistent retrovirus in mice.
Journal of acquired immune deficiency syndromes 1991;4(5):506-12.
-
1990: Warren R P; Sidwell R W; Huffman J H; Call E W; Healey M C; Johnston A V; Radov L A; Murray R J; Kinsolving C R
Effect of oxamisole on immune parameters of mice infected with murine hepatitis.
International journal of immunopharmacology 1990;12(6):625-30.
-
1990: Morrey J D; Warren R P; Okleberry K M; Burger R A; Johnston M I; Sidwell R W
Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infection.
Journal of acquired immune deficiency syndromes 1990;3(5):500-10.
-
1990: Sidwell R W; Huffman J H; Schafer T W; Shipman C
Influence of vehicle on topical efficacy of 2-acetylpyridine thiosemicarbazone and related derivatives on in vivo type 2 herpes simplex virus infections.
Chemotherapy 1990;36(1):58-69.
-
1988: Sidwell R W; Huffman J H; Barnard D L; Pifat D Y
Effects of ribamidine, a 3-carboxamidine derivative of ribavirin, on experimentally induced Phlebovirus infections.
Antiviral research 1988;10(4-5):193-207.
-
1988: Burns N J; Barnett B B; Huffman J H; Dawson M I; Sidwell R W; De Clercq E; Kende M
A newly developed immunofluorescent assay for determining the Pichinde virus-inhibitory effects of selected nucleoside analogues.
Antiviral research 1988;10(1-3):89-98.
-
1988: Sidwell R W; Huffman J H; Barnett B B; Pifat D Y
In vitro and in vivo Phlebovirus inhibition by ribavirin.
Antimicrobial agents and chemotherapy 1988;32(3):331-6.
-
1987: Sidwell R W; Huffman J H; Call E W; Warren R P; Radov L A; Murray R J
Inhibition of murine hepatitis virus infections by the immunomodulator 2,3,5,6,7,8-hexahydro-2-phenyl-8,8-dimethoxy-imidazo[1,2a]pyridine (PR-879-317A).
Antimicrobial agents and chemotherapy 1987;31(7):1130-4.
-
1987: Sidwell R W; Huffman J H; Call E; Alaghamandan H; Dixon G J
Effect of vidarabine in dimethyl sulfoxide vehicle on type 1 herpesvirus-induced cutaneous lesions in laboratory animals.
Chemotherapy 1987;33(2):141-50.
-
1987: Warren R P; Healey M C; Johnston A V; Sidwell R W; Radov L A; Murray R J; Kinsolving C R
PR 879-317A enhances in vitro immune activity of peripheral blood mononuclear cells from patients with Down syndrome.
International journal of immunopharmacology 1987;9(8):919-26.
-
1986: Sidwell R W; Huffman J H; Call E W; Alaghamandan H; Cook P D; Robins R K
Effect of selenazofurin on influenza A and B virus infections of mice.
Antiviral research 1986;6(6):343-53.
-
1985: Sidwell R W; Huffman J H; Call E W; Alaghamandan H; Cook P D; Robins R K
Activity of selenazofurin against influenza A and B viruses in vitro.
Antimicrobial agents and chemotherapy 1985;28(3):375-7.
-
1984: Morrey J D; Sidwell R W; Noble R L; Barnett B B; Mahoney A W
Effects of folic acid malnutrition on rotaviral infection in mice.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1984;176(1):77-83.
-
1983: Noble R L; Sidwell R W; Mahoney A W; Barnett B B; Spendlove R S
Influence of malnutrition and alterations in dietary protein on murine rotaviral disease.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1983;173(3):417-26.
-
1982: Smee D F; Sidwell R W; Clark S M; Barnett B B; Spendlove R S
Inhibition of rotaviruses by selected antiviral substances: mechanisms of viral inhibition and in vivo activity.
Antimicrobial agents and chemotherapy 1982;21(1):66-73.
-
1981: Smee D F; Sidwell R W; Clark S M; Barnett B B; Spendlove R S
Inhibition of bluetongue and Colorado tick fever orbiviruses by selected antiviral substances.
Antimicrobial agents and chemotherapy 1981;20(4):533-8.
-
1981: Smee D F; Sidwell R W; Barnett B B; Spendlove R S; Sharma R P
Development of antiviral levels of ribavirin in serum and urine of orally treated rats.
Chemotherapy 1981;27(1):12-7.
-
1981: Smee D F; Sidwell R W; Barnett B B; Spendlove R S
Bioassay system for determining ribavirin levels in human serum and urine.
Chemotherapy 1981;27(1):1-11.
Sign-in to see more